Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DMLA1QD)

Drug Name

MB-101 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Recurrent glioblastoma	2A00.00	Phase 1	[1]

Cross-matching ID

Molecule(s) Related to This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Interleukin 13 receptor alpha-2 (IL13RA2)	TTMPZ7V	I13R2_HUMAN	Immunomodulator	[2]

------------------------------------------------------------------------------------

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease

Recurrent glioblastoma

ICD Disease Classification

2A00.00

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Interleukin 13 receptor alpha-2 (IL13RA2)	DTT	IL13RA2	4.40E-01	2.46	1
Interleukin 13 receptor alpha-2 (IL13RA2)	DTT	IL13RA2	5.77E-05	4.14	2.11

Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)